Saizen SubQ
Generic Name: SOMATROPIN - INJECTION
Pronounced: (so-mah-TROW-pin)
Saizen SubQ Uses
Various brands of this medication are used for the treatment of
one of the following medical conditions: growth failure, growth
hormone deficiency, intestinal disorder (short bowel syndrome) or
HIV-related weight loss or wasting.
Somatropin is also used to increase height in children with a
certain genetic disorder (Noonan syndrome).
How To Use Saizen SubQ
Some brands of this medication are given by injection into a
muscle or under the skin. Some brands may only be injected under
the skin. The way you inject this medicine will depend on the brand
that you are using. Check with your pharmacist to ensure that the
way you are injecting your medicine is correct. It is important to
change the location of the injection site to avoid problem areas
under the skin. For best results, this medication must be used
exactly as prescribed by your doctor. It is important to understand
your therapy and to follow your doctor's instructions closely.
If this medicine is used for short bowel syndrome, consult your
doctor if a special diet (high carbohydrate/lowfat) or the use of
nutritional supplements may be helpful.
If this medicine is used for weight loss/muscle wasting, it may
take up to 2 weeks to notice the effects of the drug. Do not use
more of this medication than prescribed or use it more often since
the risk of side effects will be increased.
Learn how to prepare, mix, and inject your medicine correctly.
Be sure to ask your doctor or pharmacist any questions you may have
and follow the instructions for mixing provided with the
medication. Do not shake while mixing the solution. Shaking makes
the medication not work properly. Before using, check this product
visually for particles or discoloration. If either is present, do
not use the liquid. Needles and syringes are for one-time use only.
Do not reuse. Throw away used needles, syringes, and medical
supplies properly. Consult your pharmacist.
| 
Email this page
Printer friendly
Bookmark this page
